For instance, small mutated clones in the TP53 gene, present in > 0.1% of alleles, are shown to be strong predictors of poor survival and possible resistance to therapy in various neoplasms [56–59]; thus, their detection at very low abundances is pertinent for patient care. Here, TP53 is linked to neoplasm.